16 results on '"Holger S Willenberg"'
Search Results
2. Flow-dependent differentiation of cultured adrenal cells under different stimuli
- Author
-
Shaima Almansor, Katharina Mueller, Felix Friedrich, Manuela Bastian, Holger S. Willenberg, Oliver W. Hakenberg, and Paul G. Bruch
- Subjects
0301 basic medicine ,endocrine system ,Histology ,Chemistry ,Adrenal cortex ,Cell Biology ,Molecular medicine ,In vitro ,Pathology and Forensic Medicine ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,CYP17A1 ,Gene expression ,medicine ,Stem cell ,Steroid 11-beta-hydroxylase ,030217 neurology & neurosurgery ,Dexamethasone ,medicine.drug - Abstract
It still remains unclear how the functional organisation of the adrenal cortex arises. One aim of this study was to create a setup which allows for the establishment of a concentration gradient in vitro. This was achieved by a continuous flow of medium through the culture flask which caused differences in glucose and cortisol concentrations as well as in pH values between the sites of inflow and outflow of medium. Using real-time polymerase chain reaction, we found that a continuous supply of 1 ml medium per hour significantly increased the expression of MC2R, CYP11B1 and CYP17A1 genes of NCI-H295R cells in the distal area of the flask as compared with the proximal part. The expression of the AT1R showed a reverse regulation. The addition of dexamethasone to the medium led to an increase in gene expression of MC2R while AT1R was downregulated. Moreover, we detected a higher expression of CYP11B2 and a decreased expression of CYP11B1 when endothelial cell–conditioned medium (ECCM) was added to the inflow. Our experiments show that a directed medium delivery system creates different gradients and affects the functional differentiation of the NCI-H295R cells. Also, our results emphasise that products of endothelial cells have additional effects on the differentiation of the cultured adrenal cortical cells. Our results are in support that the regulation of the adrenal zonation is possible through different concentration gradients.
- Published
- 2021
3. Villus Growth, Increased Intestinal Epithelial Sodium Selectivity, and Hyperaldosteronism Are Mechanisms of Adaptation in a Murine Model of Short Bowel Syndrome
- Author
-
Ursula Seidler, Holger S. Willenberg, Änne Glass, Peggy Berlin, Georg Lamprecht, Jakob Wobar, Ernst Klar, Johannes Reiner, Karen Bannert, Maria Witte, Manuela Bastian, Brigitte Vollmar, and Michael Walter
- Subjects
Male ,Short Bowel Syndrome ,medicine.medical_specialty ,Physiology ,Intestinal adaptation ,Gastroenterology ,Muscle hypertrophy ,Mice ,Random Allocation ,03 medical and health sciences ,chemistry.chemical_compound ,Organ Culture Techniques ,0302 clinical medicine ,Weight loss ,Internal medicine ,Hyperaldosteronism ,medicine ,Animals ,Intestinal Mucosa ,Aldosterone ,Clinical outcome ,business.industry ,Sodium ,digestive, oral, and skin physiology ,Ileocecal resection ,Intestinal failure ,Hepatology ,medicine.disease ,Short bowel syndrome ,Mice, Inbred C57BL ,Disease Models, Animal ,Diarrhea ,chemistry ,030220 oncology & carcinogenesis ,Paracellular transport ,Original Article ,030211 gastroenterology & hepatology ,medicine.symptom ,business - Abstract
Background Short bowel syndrome results from extensive small bowel resection and induces adaptation of the remaining intestine. Ileocecal resection (ICR) is the most frequent situation in humans. Villus hypertrophy is one hallmark of mucosal adaptation, but the functional mechanisms of mucosal adaptation are incompletely understood. Aims The aim of the study was to characterize a clinically relevant model of short bowel syndrome but not intestinal failure in mice and to identify outcome predictors and mechanisms of adaptation. Methods Male C57BL6/J mice underwent 40% ICR and were followed for 7 or 14 days. Small bowel transection served as control. All mice underwent autopsy. Survival, body weight, wellness score, stool water content, plasma aldosterone concentrations, and paracellular permeability were recorded. Results Unlike controls, resected mice developed significant diarrhea with increased stool water. This was accompanied by sustained weight loss throughout follow-up. Villus length increased but did not correlate positively with adaptation. Plasma aldosterone concentrations correlated inversely with body weight at day 14. After ICR, intestinal epithelial (i.e., tight junctional) sodium permeability was increased. Conclusions 40% ICR results in moderate to severe short bowel syndrome. Successful adaptation to the short bowel situation involves villus elongation but does not correlate with the degree of villus elongation alone. In addition, increased intestinal epithelial sodium permeability facilitates sodium-coupled solute transport. Hyperaldosteronism correlates with the severity of weight loss, indicates volume depletion, and counterregulates water loss. Electronic supplementary material The online version of this article (10.1007/s10620-018-5420-x) contains supplementary material, which is available to authorized users.
- Published
- 2018
4. Biomechanics of the osteoporotic spine, pain, and principles of training
- Author
-
Guenther Kundt, G Schröder, Detlef Wendig, Andreas Knauerhase, Hans-Christof Schober, and Holger S. Willenberg
- Subjects
Male ,medicine.medical_specialty ,Sling (implant) ,Osteoporosis ,Clinical manifestation ,Spine pain ,03 medical and health sciences ,0302 clinical medicine ,Physical medicine and rehabilitation ,Activities of Daily Living ,medicine ,Humans ,Orthopedics and Sports Medicine ,In patient ,Muscle Strength ,Physical Therapy Modalities ,Aged ,030222 orthopedics ,business.industry ,Biomechanics ,Chronic pain ,General Medicine ,medicine.disease ,Spine ,Biomechanical Phenomena ,Exercise Therapy ,Treatment Outcome ,Orthopedic surgery ,Physical therapy ,Female ,Spinal Diseases ,Surgery ,Chronic Pain ,business ,030217 neurology & neurosurgery - Abstract
A fracture is a clinical manifestation of osteoporosis and is one of the main causes of functional limitations and chronic pain in patients with osteoporosis. Muscle and coordination training are recommended to the patients as general measures. We inquired whether sling training is better than traditional physiotherapy in relieving pain and improving abilities of daily living. Fifty patients with osteoporosis were divided into two groups. Group A performed conventional physiotherapy, while Group B performed sling training exercises. Data were collected before and after the intervention and after 3 months. The registered parameters were stamina, posture, and pain. Posture, torques, and the associated strength of spinal muscles were studied in a biomechanical model in order to estimate the forces acting on the spine. Furthermore, the factors that exerted a positive impact on the success of therapy were registered. Forty-four patients (88%) completed the study. Positive effects of the training were noted in both groups, but significantly better effects were observed in the group that performed sling training. A reduction of pain independent of the number of fractures, significantly reduced torques, and reduced muscle strength were registered. Specific training programs helped to increase muscle strength and straightening the back thereby reducing the force needed on a permanent basis and decreasing torque in the spine. Sling training was more effective in that than traditional physiotherapy.
- Published
- 2017
5. Wichtige Aspekte des Nebennierenrindenkarzinoms
- Author
-
Holger S. Willenberg
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Oncology ,business.industry ,030220 oncology & carcinogenesis ,medicine ,030209 endocrinology & metabolism ,Hematology ,business - Abstract
Das Nebennierenrindenkarzinom ist eine seltene Erkrankung. Dieser Beitrag soll dazu dienen, uber die Genese, die klinischen Symptome und hormonellen Besonderheiten sowie diagnostische und therapeutische Strategien bei dieser Entitat zu informieren. Gerade in den letzten Jahren wurden diverse Erkenntnisse zur Molekularbiologie des Nebennierenrindenkarzinoms gewonnen, und es ergaben sich neue diagnostische und therapeutische Moglichkeiten fur die Betreuung hiervon betroffener Patienten. Sie schliesen hormonelle, nuklearmedizinisch-radiologische, histopathologische und genetische Untersuchungen mit ein. Um eine gute Lebensqualitat und -quantitat zu erzielen, richten sich die therapeutischen Bemuhungen nach der lokalen Kontrolle, der Metastasierung und den hormonellen Veranderungen, die durch den Tumor oder die einzelnen Therapieformen provoziert werden und neben der Tumorbiologie und dem Alter prognostisch entscheidend sind. Auch hier konnten Daten zur Wirkweise und Effektivitat von Medikamenten gewonnen und verfugbar gemacht werden. Eine interdisziplinare spezialisierte Diagnostik und Betreuung zu Beginn und im Verlauf der Erkrankung sind eine notwendige Voraussetzung fur optimale Ergebnisse in der Therapie des Nebennierenrindenkarzinoms. Fur den Patienten lassen sich durch die Kombination verschiedener Therapieformen und die fruhe adjuvante Behandlung oft die besten Resultate bezuglich des Uberlebens und die optimale Lebensqualitat erzielen. Um die Studienlage zu verbessern und die Betreuung der Patienten mit Nebennierenrindenkarzinom weiterzuentwickeln, wurden nationale und internationale Netzwerke gegrundet.
- Published
- 2016
6. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
- Author
-
Gerald Goh, Carol Nelson-Williams, Reju Korah, Murim Choi, Peyman Björklund, Peter Stålberg, James M. Healy, Tobias Carling, Matthias Haase, Manju L. Prasad, Dimo Dietrich, John W. Kunstman, Richard P. Lifton, Ute I. Scholl, Holger S. Willenberg, Göran Åkerström, Anna-Carinna Suttorp, and Per Hellman
- Subjects
0303 health sciences ,Mutation ,Protein subunit ,Adrenal Gland Neoplasm ,030209 endocrinology & metabolism ,Biology ,medicine.disease_cause ,Molecular biology ,PRKACA ,03 medical and health sciences ,0302 clinical medicine ,Cdc42 GTP-Binding Protein ,Genetics ,medicine ,Cancer research ,Phosphorylation ,Protein kinase A ,PRKAR1A ,030304 developmental biology - Abstract
Richard Lifton and colleagues identify a recurrent activating mutation in PRKACA, which encodes the catalytic subunit of protein kinase A, in cortisol-producing adrenal tumors. They further show that the mutation results in loss of binding by the regulatory subunit PRKAR1A, leading to increased phosphorylation of downstream targets.
- Published
- 2014
7. Activating mutations in CTNNB1 in aldosterone producing adenomas
- Author
-
Peter Stålberg, Martin K. Walz, K. Alexander Iwen, Peyman Björklund, Rajani Maharjan, Hendrik Lehnert, Per Hellman, Bruce G. Robinson, Stan B. Sidhu, Holger S. Willenberg, Tobias Åkerström, Henning Dralle, Julian C. Y. Ip, Kenko Cupisti, Celso E. Gomez-Sanchez, and Ana Moser
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Beta-catenin ,Secondary hypertension ,030209 endocrinology & metabolism ,medicine.disease_cause ,Article ,03 medical and health sciences ,Exon ,chemistry.chemical_compound ,0302 clinical medicine ,Protein Domains ,Internal medicine ,KCNJ5 ,medicine ,AXIN2 ,Humans ,Aldosterone ,Wnt Signaling Pathway ,beta Catenin ,Mutation ,Multidisciplinary ,biology ,business.industry ,Wnt signaling pathway ,Exons ,medicine.disease ,Adrenal Cortex Neoplasms ,Neoplasm Proteins ,030104 developmental biology ,Endocrinology ,chemistry ,Adrenocortical Adenoma ,biology.protein ,Female ,business - Abstract
Primary aldosteronism (PA) is the most common cause of secondary hypertension with a prevalence of 5–10% in unreferred hypertensive patients. Aldosterone producing adenomas (APAs) constitute a large proportion of PA cases and represent a surgically correctable form of the disease. The WNT signaling pathway is activated in APAs. In other tumors, a frequent cause of aberrant WNT signaling is mutation in the CTNNB1 gene coding for β-catenin. Our objective was to screen for CTNNB1 mutations in a well-characterized cohort of 198 APAs. Somatic CTNNB1 mutations were detected in 5.1% of the tumors, occurring mutually exclusive from mutations in KCNJ5, ATP1A1, ATP2B3 and CACNA1D. All of the observed mutations altered serine/threonine residues in the GSK3β binding domain in exon 3. The mutations were associated with stabilized β-catenin and increased AXIN2 expression, suggesting activation of WNT signaling. By CYP11B2 mRNA expression, CYP11B2 protein expression and direct measurement of aldosterone in tumor tissue, we confirmed the ability for aldosterone production. This report provides compelling evidence that aberrant WNT signaling caused by mutations in CTNNB1 occur in APAs. This also suggests that other mechanisms that constitutively activate the WNT pathway may be important in APA formation.
- Published
- 2016
8. Trends in adrenal surgery: institutional review of 528 consecutive adrenalectomies
- Author
-
Andreas Raffel, Achim Wolf, Holger S. Willenberg, Matthias Schott, Anja Lachenmayer, Kenko Cupisti, Wolfram T. Knoefel, and Claus F. Eisenberger
- Subjects
Diagnostic Imaging ,Male ,medicine.medical_specialty ,Adrenal surgery ,Adrenal Gland Neoplasms ,chemistry.chemical_compound ,Postoperative Complications ,Germany ,Adrenal Glands ,medicine ,Humans ,Single institution ,Adrenal tumors ,Retrospective Studies ,Chi-Square Distribution ,Aldosterone ,business.industry ,General surgery ,Adrenalectomy ,Retrospective cohort study ,Length of Stay ,Middle Aged ,Vascular surgery ,Surgery ,Treatment Outcome ,chemistry ,Cardiothoracic surgery ,Female ,Laparoscopy ,business ,Abdominal surgery - Abstract
The increasing detection of adrenal tumors and the availability of a more sophisticated biochemical work-up leading to rising numbers of sub-clinical Conn's and Cushing's syndromes coincide with a rising number of adrenalectomies worldwide. The aim of our study was to report a single institution's experience with adrenal surgery.We report data of 528 adrenalectomies, operated at our institution before and after the onset of minimally invasive endoscopic surgery (1986-1994, 1995-2008). Gender, age, indication, imaging, surgical approach, operating time, histology, tumor size, hospital stay, and complications were analyzed retrospectively.A total of 478 patients underwent adrenal surgery during the time observed. The average number of yearly adrenalectomies increased from 14 to 21 (p = 0.001) after the onset of laparoscopic surgery. Imaging techniques showed a significant shift towards magnetic resonance imaging (p 0.001) and preoperative assessment of tumor size was significantly correlated to malignancy: 10.8 % (11/102) and 42 % (21/50) of tumors measuring 4-6 cm and ≥6 cm, respectively, were malignant in the final histology report (p 0.001). Patients operated by minimally invasive endoscopy were significantly younger (mean 49.4 years, p = 0.046), had significantly shorter operating times (mean 118 min, p 0.001), had shorter hospital stays (mean 7.1 days, p 0.001), and had less complications (6.9 %, p = 0.004) compared to patients resected through open procedures.Although adrenalectomy rates increased and minimally invasive endoscopic surgery reduced hospital stay and complications at our institution, the yearly number of procedures was still low with often high surgical complexity. We therefore believe that adrenal surgery remains a highly specialized procedure that should preferably be performed at endocrine surgery centers.
- Published
- 2012
9. A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma
- Author
-
Elke Kaminsky, Matthias Schott, Holger S. Willenberg, Matthias Haase, Sven Schinner, Martin Anlauf, and Werner A. Scherbaum
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,endocrine system ,endocrine system diseases ,Tumor suppressor gene ,Endocrinology, Diabetes and Metabolism ,Neuroendocrine tumors ,Biology ,Fatal Outcome ,Endocrinology ,Proto-Oncogene Proteins ,Adrenocortical Carcinoma ,Multiple Endocrine Neoplasia Type 1 ,medicine ,Humans ,Point Mutation ,Adrenocortical carcinoma ,Endocrine system ,Neoplasm Invasiveness ,MEN1 ,Multiple endocrine neoplasia ,Family Health ,Adrenal cortex ,Middle Aged ,medicine.disease ,Adrenal Cortex Neoplasms ,medicine.anatomical_structure ,Cancer research ,Female ,Pancreas - Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor syndrome that may be caused by mutations in the MEN1 gene on 11q13. Loss of function of the tumor suppressor gene MEN1 leads to synchronous or metachronous appearance of neuroendocrine tumors arising from neuroendocrine cells of the parathyroid and pituitary glands, the duodenum and pancreatic islets, and other endocrine organs such as the adrenal cortex. We here present a patient with MEN1 who developed hyperparathyroidism, multiple well differentiated functionally inactive neuroendocrine tumors of the pancreas and an adrenal carcinoma. We describe a new mutation at codon 443 in the coding region of exon 9 in the MEN1 gene, where a cytosine residue was exchanged for adenosine (TCCTAC) and, consequently, serine for tyrosine (p.Ser443Tyr; c.1328CA). [corrected] Also, we provide clinical data that may add to the genotype-phenotype discussion. We conclude that the novel mutation in the MEN1 gene described herein was clinically relevant.
- Published
- 2010
10. Grundlagen und Management der glukokortikoidinduzierten Osteoporose
- Author
-
Hendrik Lehnert and Holger S. Willenberg
- Subjects
Gynecology ,Fracture risk ,medicine.medical_specialty ,business.industry ,Internal Medicine ,medicine ,Bone mass density ,business - Abstract
Glukokortikoide beeintrachtigen den Knochenstoffwechsel auf verschiedenen Ebenen. Entsprechend ist die glukokortikoidinduzierte Osteoporose (GIO) die haufigste Form der sekundaren Osteoporose, und bis zu 50% der Patienten mit chronischer Glukokortikoidtherapie erleiden Frakturen. Das liegt u. a. auch daran, dass diese Osteoporoseform immer noch zu wenig diagnostiziert und behandelt wird. Auserdem ist das Frakturrisiko bei vergleichbarer Knochendichte gegenuber dem der primaren Ostepoporose erhoht. Das Frakturrisiko wird wesentlich durch die Hohe der Glukokortikoiddosis und die Dauer der Behandlung bestimmt, wenngleich der Knochenmasseverlust innerhalb der ersten 3–12 Monate nach Beginn der Glukokortikoidtherapie am grosten ist. Daneben haben auch weitere Faktoren – wie insbesondere die Grunderkrankung – wesentlichen Einfluss auf das Frakturrisiko. Ein diagnostisches Basisprogramm ist deshalb in allen Fallen notwendig und beinhaltet neben einer spezifischen Anamnese die korperliche Untersuchung, Laborbestimmungen, Knochendichtemessung und bildgebende Untersuchungen. Die Aufklarung und die medikamentose Pravention haben einen hohen Stellenwert, antiresorptive Therapeutika werden fruher eingesetzt als bei primarer Osteoporose, und auch die osteoanabole Therapie ist effektiv. Die evidenzbasierten Leitlinien des Dachverbands Osteologie stellen eine sehr wertvolle Hilfe bei der Betreuung betroffener Patienten dar.
- Published
- 2008
11. heochromocytoma : current diagnostics and treatment
- Author
-
Holger S. Willenberg
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Medizin ,medicine ,General Medicine ,business - Abstract
Der Bluthochdruck ist ein typisches Symptom eines Phaochromo-zytoms. Doch daneben bestehen haufig viele weitere Beschwerden, die die Diagnostik nicht gerade erleichtern. Unsere Autoren zeigen Ihnen den diagnostischen Weg auf, den Sie verfolgen sollten, wenn Sie aufgrund einer entsprechenden Klinik bei einem Patienten Verdacht schopfen.
- Published
- 2010
12. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function
- Author
-
N Hiroi, G Päth, Holger S. Willenberg, Werner A. Scherbaum, Stefan R. Bornstein, Peter E. Goretzki, and George P. Chrousos
- Subjects
Adult ,endocrine system ,medicine.medical_specialty ,Hydrocortisone ,Transcription, Genetic ,Corticotropin-Releasing Hormone ,medicine.drug_class ,Chromaffin Cells ,Corticotropin-releasing hormone receptor ,Enteroendocrine cell ,Receptors, Corticotropin-Releasing Hormone ,Cell Line ,Cellular and Molecular Neuroscience ,Adrenocorticotropic Hormone ,Internal medicine ,polycyclic compounds ,medicine ,Animals ,Humans ,Pyrroles ,Antalarmin ,Receptor ,Molecular Biology ,Cells, Cultured ,Reverse Transcriptase Polymerase Chain Reaction ,Adrenal gland ,Chemistry ,Antagonist ,Haplorhini ,Receptor antagonist ,Coculture Techniques ,Rats ,Psychiatry and Mental health ,Pyrimidines ,medicine.anatomical_structure ,Endocrinology ,Gene Expression Regulation ,nervous system ,Adrenal Medulla ,Pituitary Gland ,Chromaffin cell ,Adrenal Cortex ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug - Abstract
Corticotropin-releasing hormone (CRH) is the principal regulator of the hypothalamic-pituitary-adrenal (HPA) axis and an activator of the sympathoadrenal (SA) and systemic sympathetic (SS) systems. Mental disorders, including major depression and, more recently, Alzheimer's disease have been associated with dysregulation of the HPA axis and the SA/SS systems. Treatment of rats or monkeys with the novel CRH receptor type 1 (CRH-R1) antagonist antalarmin inhibits the HPA and/or the SA/SS axes. This is the first study to examine the potential direct effect of antalarmin on human adrenal function. Adrenocortical and adrenomedullary cells were characterized by double-immunohistochemistry with anti-17 alpha hydroxylase (cortical cells) and anti-chromogranin A (chromaffin cells). Expression of CRH, ACTH, CRH type I and type II receptor mRNA were analyzed by reverse-transcription (RT) PCR. Human adrenal cortical and/or chromaffin cells in co-culture were incubated with CRH, antalarmin, and both CRH and antalarmin in vitro. Exposure of these cells to corticotropin or vehicle medium served as positive and negative controls, respectively. Cortical and chromaffin tissues were interwoven in the human adrenals, and both in situ and in the co-culture system the endocrine cell types were in close cellular contact. ACTH, CRH, and CRH-R1 and CRH-R2 mRNAs were expressed in the human adrenal as determined by RT-PCR. CRH (10-8 M) led to a moderate increase of cortisol release (145.7 +/- 20.0%) from cortical and chromaffin adrenal cells in co-culture. This effect corresponded to 41.8% of the maximal increase induced by ACTH (10-8 M). The action of CRH was completely inhibited by antalarmin. CRH, ACTH, and both CRH-R1 and CRH-R2 mRNAs are expressed in the adult human adrenal gland. CRH stimulates cortisol production in cortical and chromaffin cell co-cultures. This effect is blocked by antalarmin, a selective CRH-R1 receptor antagonist, suggesting that CRH-R1 receptors are involved in an intraadrenal CRH/ACTH control system in humans.
- Published
- 2000
13. Fortschritte in der molekularen medizin: Die 'Laser Capture Microdissection'
- Author
-
Holger S. Willenberg, Wener A. Scherbaum, and Stefan R. Bornstein
- Subjects
business.industry ,Medicine ,General Medicine ,business ,Molecular biology - Abstract
□ Hintergrund Mit der Entschlusselung des menschlichen Genoms stellt sich die grose Aufgabe, Funktion und klinische Bedeutung der einzelnen Gene zu definieren. Dabei sollte es moglich sein, gesunde und kranke Zellen gezielt aus der komplexen Struktur des Gewebes zu isolieren und sie der sensitiven molekularen Analyse zuganglich zu machen. Die „Laser Capture Microdissection” (LCM) wurde entwickelt, um diese Aufgabe zu erfullen.
- Published
- 1998
14. A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels
- Author
-
Reiner Füth, Werner A. Scherbaum, Mark Lankisch, Sven Schinner, Matthias Schott, Holger S. Willenberg, Stephan Martin, Kerstin Kempf, and Wilfried Dinh
- Subjects
Blood Glucose ,Male ,lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,oral glucose tolerance test ,Coronary Angiography ,Impaired glucose tolerance ,impaired fasting glucose ,Risk Factors ,cardiovascular disease ,Internal medicine ,Diabetes mellitus ,Prevalence ,medicine ,Humans ,Risk factor ,Aged ,Retrospective Studies ,Original Investigation ,Angiology ,business.industry ,Coronary Stenosis ,Retrospective cohort study ,Odds ratio ,Middle Aged ,medicine.disease ,Impaired fasting glucose ,Logistic Models ,impaired glucose tolerance ,Endocrinology ,lcsh:RC666-701 ,Hyperglycemia ,diabetes mellitus ,Disease Progression ,Cardiology ,Population study ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Objective Diabetes mellitus type 2 (DM2) is a risk factor for coronary heart disease (CHD). While there is a clear correlation of fasting blood glucose (FBG) and 2 h post-challenge blood glucose values (2h-BG) with microvascular complications, the risk for CHD conferred by glucose dysregulation antecedent to DM2 is less clear. Therefore, we investigated associations of FBG and 2h-BG values with the prevalence of CHD assessed by coronary angiography as the most sensitive diagnostic tool. Research Design and Methods Coronary angiography was performed in 1394 patients without known DM. Capillary blood glucose was analyzed before and 2 h after an oral glucose tolerance test. Associations between FBG as well as 2h-BG levels and the risk for CHD were assessed by logistic regression analysis. Results 1064 (75%) of patients were diagnosed with CHD. 204 (15%) were diagnosed with so far unknown DM2, 274 (20%) with isolated impaired fasting glucose (IFG), 188 (13%) with isolated impaired glucose tolerance (IGT) and 282 (20%) with both, IGT and IFG. We found a continuous increase in the risk for CHD with fasting and post-challenge blood glucose values even in the subdiabetic range. This correlation did however not suggest clear cut-off values. The increase in risk for CHD reached statistical significance at FBG levels of > 120 mg/dl (Odds Ratio of 2.7 [1.3-5.6] and 2h-BG levels > 140 mg/dl (141-160 mg/dl OR 1.8 [1.1-2.9], which was however lost after adjusting for age, sex and BMI. Conclusions In our study population we found a continuous increased risk for CHD at fasting and 2h-BG levels in the sub-diabetic glucose range, but no clear cut-off values for cardiovascular risk.
- Published
- 2011
15. Insulin gene polymorphisms in type 1 diabetes, Addison's disease and the polyglandular autoimmune syndrome type II
- Author
-
Jürgen Seissler, Holger S. Willenberg, Elizabeth Ramos-Lopez, Klaus Badenhoop, Heinrich Kahles, Nicole Reisch, Britta Lange, Gesine Meyer, Stefanie Hahner, and Marissa Penna-Martinez
- Subjects
Adult ,lcsh:Internal medicine ,medicine.medical_specialty ,Adolescent ,Genotype ,lcsh:QH426-470 ,endocrine system diseases ,Graves' disease ,medicine.medical_treatment ,Hashimoto Disease ,Minisatellite Repeats ,Biology ,medicine.disease_cause ,Polymerase Chain Reaction ,Autoimmunity ,Addison Disease ,Diabetes mellitus ,Internal medicine ,Genetics ,medicine ,Humans ,Insulin ,Genetics(clinical) ,Child ,Polyendocrinopathies, Autoimmune ,lcsh:RC31-1245 ,Alleles ,Genetics (clinical) ,Type 1 diabetes ,Chi-Square Distribution ,Polymorphism, Genetic ,Infant ,Middle Aged ,medicine.disease ,Graves Disease ,lcsh:Genetics ,Diabetes Mellitus, Type 1 ,Endocrinology ,medicine.anatomical_structure ,Case-Control Studies ,Child, Preschool ,Addison's disease ,Pancreas ,Research Article - Abstract
Background Polymorphisms within the insulin gene can influence insulin expression in the pancreas and especially in the thymus, where self-antigens are processed, shaping the T cell repertoire into selftolerance, a process that protects from β-cell autoimmunity. Methods We investigated the role of the -2221Msp(C/T) and -23HphI(A/T) polymorphisms within the insulin gene in patients with a monoglandular autoimmune endocrine disease [patients with isolated type 1 diabetes (T1D, n = 317), Addison's disease (AD, n = 107) or Hashimoto's thyroiditis (HT, n = 61)], those with a polyglandular autoimmune syndrome type II (combination of T1D and/or AD with HT or GD, n = 62) as well as in healthy controls (HC, n = 275). Results T1D patients carried significantly more often the homozygous genotype "CC" -2221Msp(C/T) and "AA" -23HphI(A/T) polymorphisms than the HC (78.5% vs. 66.2%, p = 0.0027 and 75.4% vs. 52.4%, p = 3.7 × 10-8, respectively). The distribution of insulin gene polymorphisms did not show significant differences between patients with AD, HT, or APS-II and HC. Conclusion We demonstrate that the allele "C" of the -2221Msp(C/T) and "A" -23HphI(A/T) insulin gene polymorphisms confer susceptibility to T1D but not to isolated AD, HT or as a part of the APS-II.
- Published
- 2008
16. Corrigendum: Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
- Author
-
Richard P. Lifton, James M. Healy, John W. Kuntsman, Peter Stålberg, Matthias Haase, Gerald Goh, Reju Korah, Murim Choi, Anna Carinna Suttorp, Ute I. Scholl, Holger S. Willenberg, Tobias Carling, Per Hellman, Peyman Björklund, Carol Nelson-Williams, Dimo Dietrich, Göran Åkerström, and Manju L. Prasad
- Subjects
endocrine system ,Genetics ,Cancer research ,Biology ,Activating mutation ,Adrenal tumors ,hormones, hormone substitutes, and hormone antagonists ,PRKACA - Abstract
Corrigendum: Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.